About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
I
ASCO® GI 2024 Insights: "NIVOFGFR2 Study - Nivo and CapeOX in Patients With Previously Untreated FGFR2+, PD-L1+ Advanced Gastric Cancer"
By
Insights from 2024 ASCO® GI Annual Meeting
FEATURING
Ilya Tsimafeyeu
By
Insights from 2024 ASCO® GI Annual Meeting
FEATURING
Ilya Tsimafeyeu
91 views
January 31, 2024
0 Comments
Login to view comments.
Click here to Login
Featured Video
10:25
Exelixis
Explore the mechanism of Action of a TKI in HCC
Feat.
W. Keiser
Featured Video
15:07
Exelixis
Safety and Efficacy Data of a TKI Monotherapy in HCC
Feat.
J. Mizrahi
Related Content
AUTOPLAY
ON
57:44
Vogl, NY
Vogl,NY on How to Ask Good Questions at Medical Meetings
Feat.
S. Vogl
27:37
ASCO GI 2023 Conference Coverage
ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates
Feat.
N. Uboha,
A. Turk,
K. Spencer,
M. Cecchini
23:58
ASCO GI 2023 Conference Coverage
ASCO GI 2023 Key Studies
Feat.
R. Kim,
R. Mehta
27:12
Moffitt Cancer Center
Year in Review: Upper GI Cancers
Feat.
R. Kim,
R. Mehta
17:50
AdventHealth
Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…
Feat.
G. Sonpavde
07:35
Insights from 2024 ASCO® GI Annual Meeting
ASCO® GI 2024 Summary: "Gastro-Esophageal Key Studies Including…
Feat.
R. Kim,
R. Mehta
13:47
Aditya Shreenivas
Neoadjuvant IO in MSI-High GI Cancers: Special Focus on the DREAM GI…
Feat.
S. Chakrabarti
09:42
Insights from 2024 ASCO® GI Annual Meeting
ASCO® GI 2024 Panel Discussion: "MATTERHORN & KEYNOTE-585 C…
Feat.
Y. Janjigian,
S. Cytryn,
S. Klempner
23:27
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Summary: "GI Key Studies Including MATTERHORN & K…
Feat.
R. Kim,
R. Mehta
29:25
Young Chae
Hyperprogression in Cancer Treated With Immunotherapy
19:41
Balazs Halmos
How I Manage Immune Adverse Events in Solid Tumors
23:26
Yale Cancer Center
GI Cancer Updates: The Role of Surgery After Neoadjuvant Systemic Th…
Feat.
C. Balch
18:51
Hope for Stomach Cancer
1L Therapy for Stage 4 Gastroesophageal Cancers: The Role of Biomark…
Feat.
D. Catenacci
16:53
Scripps MD Anderson Cancer Center
GC/GEJC/EC Trials - Evolving Landscape and Treatment Guidance
Feat.
J. Hecht
10:23
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "Randomized Phase 3 GASTFOX Study - 5-fluor…
Feat.
A. Zaanan
04:18
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Biomarker Analysis of 2 Zolbetuximab Phas…
Feat.
K. Shitara
03:31
ecancer
ESMO 2023 Summary: "Highlights From Recent GI Cancer Trials&quo…
Feat.
B. Gyawali
08:35
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Phase 3 ATTRACTION-5 Study - Nivo + Chemo…
Feat.
M. Terashima
20:44
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Panel Discussion: "Upper GI Cancers"
Feat.
S. Cytryn,
F. Pietrantonio,
G. Argiles Martinez
09:58
Elizabeth Smyth
Controversies in the Predictive Value of PD-L1 for Anti-PD-1 Benefit…
Feat.
R. Sundar
